Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CpPI(4)K inhibitors(Cryptosporidium PI4K inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H21ClN4O4 |
InChIKeyUUGWSUYPJGPKKF-UHFFFAOYSA-N |
CAS Registry2767264-57-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cryptosporidiosis | Phase 1 | United Kingdom | 29 Apr 2022 |